Variant report
Variant | esv3426216 |
---|---|
Chromosome Location | chr6:27767581-27768090 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:27098199..27102217-chr6:27766076..27771196,5 | MCF-7 | breast: | |
2 | chr6:27111619..27120059-chr6:27760198..27767915,14 | K562 | blood: | |
3 | chr6:27113702..27117076-chr6:27765756..27767872,3 | MCF-7 | breast: | |
4 | chr6:27763449..27765293-chr6:27766819..27768521,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000184825 | chromatin interactions |
ENSG00000124635 | chromatin interactions |
ENSG00000196787 | chromatin interactions |
ENSG00000197903 | chromatin interactions |
ENSG00000265565 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151149852 | chr6:27767600-27767601 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
2 | rs200474 | chr6:27767640-27767641 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs572916668 | chr6:27767689-27767690 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
4 | rs149863337 | chr6:27767704-27767705 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
5 | rs558524984 | chr6:27767705-27767706 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
6 | rs544708213 | chr6:27767714-27767715 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
7 | rs147960031 | chr6:27767774-27767775 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
8 | rs9393856 | chr6:27767825-27767826 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs374469321 | chr6:27767839-27767840 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
10 | rs60309107 | chr6:27767840-27767841 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
11 | rs529383122 | chr6:27767850-27767851 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
12 | rs186198105 | chr6:27767876-27767877 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
13 | rs559808996 | chr6:27767889-27767890 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
14 | rs528632897 | chr6:27767909-27767910 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
15 | rs9348778 | chr6:27767936-27767937 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs527967728 | chr6:27767958-27767959 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs111259075 | chr6:27767959-27767960 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs374630714 | chr6:27767989-27767990 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs368118102 | chr6:27767998-27767999 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs141809844 | chr6:27768007-27768008 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs189864452 | chr6:27768012-27768013 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs201618806 | chr6:27768013-27768014 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs535859640 | chr6:27768073-27768074 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs546247192 | chr6:27768088-27768089 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:27761200-27768600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr6:27761600-27768600 | Weak transcription | NHEK | skin |
3 | chr6:27764400-27768400 | Enhancers | K562 | blood |
4 | chr6:27764400-27774200 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr6:27764600-27768600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr6:27766600-27768400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |